Radiologically placed temporary hepatic artery catheter for treatment of liver cancer

S. Gananadha, T. D.B. Yan, J. Zhao, P. Clingan, D. Glenn, D. Morris*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Hepatic artery infusion (HAI) chemotherapy is associated with higher response rates compared to systemic chemotherapy in those patients with unresectable liver malignancies. Operative hepatic artery catheter (HAC) insertion has significant morbidity and mortality, especially in patients with high-volume disease, some of whom may not respond to HAI chemotherapy. We report our experience in 45 patients with high-volume liver disease who were initially treated with HAI chemotherapy via a radiologically placed temporary HAC to try to select the responders who then went on to have an operative HAC. In these 45 patients who had 62 radiologically placed HAC, we found very few major complications, and certainly no complications such as cholecystitis, vascular or malperfusion problems.

Original languageEnglish
Pages (from-to)396-399
Number of pages4
JournalAustralasian Radiology
Issue number5
Publication statusPublished - Oct 2005
Externally publishedYes


  • Drug therapy
  • Hepatic artery
  • Liver neoplasms
  • Radiology


Dive into the research topics of 'Radiologically placed temporary hepatic artery catheter for treatment of liver cancer'. Together they form a unique fingerprint.

Cite this